3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
56
Carcinoma, Non-Small-Cell Lung
53
Carcinoma, Renal Cell
37
Lung Neoplasms
22
Neoplasm Metastasis
21
Carcinoma, Hepatocellular
21
Stomach Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
17
Neoplasms
17
Colorectal Neoplasms
17
Carcinoma, Transitional Cell
14
Adenocarcinoma Of Esophagus
13
Prostatic Neoplasms
11
Hodgkin Disease
11
Brain Neoplasms
10
Urinary Bladder Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
8
Triple Negative Breast Neoplasms
7
Skin Neoplasms
7
Rectal Neoplasms
7
Pancreatic Neoplasms
7
Esophageal Neoplasms
7
Colonic Neoplasms
7
Clear-cell metastatic renal cell carcinoma
7
Breast Neoplasms
7
Sarcoma
6
Carcinoma, Merkel Cell
6
Carcinoma, Basal Cell
6
Uveal Melanoma
5
Interventions
dodecyl maltoside
2
Magnetic Resonance Imaging
2
Electrocardiography
2
Diphenhydramine
2
Acetaminophen
2
fludarabine phosphate
1
fludarabine
1
durvalumab
1
aldesleukin
1
Tomography, X-Ray Computed
1
Respiratory Function Tests
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Meperidine
1
Mastectomy, Subcutaneous
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Hydroxyzine
1
Histamine Antagonists
1
Granisetron
1
Droperidol
1
Doxylamine
1
Docetaxel
1
Diphenoxylate
1
Cystoscopy
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma in Situ
×
Nivolumab
×
90 days
×
Clear all
No trials found.